These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3519232)

  • 1. Adjuvant hormonotherapy for breast cancer.
    Grem JL; Carbone PP
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):235-9. PubMed ID: 3519232
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party.
    Br J Cancer; 1988 Jun; 57(6):604-7. PubMed ID: 2900646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing "the soft option": trials of adjuvant endocrine therapy for the primary treatment of breast cancer.
    Ebbs SR; Baum M
    Isr J Med Sci; 1988; 24(9-10):552-6. PubMed ID: 3060445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Christie hospital adjuvant tamoxifen trial--status at 10 years.
    Ribeiro G; Swindell R
    Br J Cancer; 1988 Jun; 57(6):601-3. PubMed ID: 3044432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant tamoxifen treatment in postmenopausal patients with operable breast cancer.
    Wallgren A; Baral E; Glas U; Karnström L; Nordenskiöld B; Theve NO; Silfverswärd C
    J Steroid Biochem; 1985 Dec; 23(6B):1161-2. PubMed ID: 3912623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant hormonal chemotherapy in early breast cancer: early results from a controlled trial.
    Senanayake F
    Lancet; 1984 Nov; 2(8412):1148-9. PubMed ID: 6150196
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen versus chemotherapy as adjuvant treatment in stage III breast cancer.
    Alagaratnam TT; Wong J
    Aust N Z J Surg; 1986 Jan; 56(1):39-41. PubMed ID: 3090987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant tamoxifen in breast cancer.
    Jakesz R; Lippman ME
    Cancer Treat Rev; 1984 Dec; 11(4):321-3. PubMed ID: 6398758
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant tamoxifen in breast cancer.
    Blum JE
    Lancet; 1987 Sep; 2(8561):747. PubMed ID: 2888974
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant systemic therapy in primary breast cancer.
    Mouridsen HT; Palshof T
    Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
    Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract]   [Full Text] [Related]  

  • 12. Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
    Stewart HJ
    Recent Results Cancer Res; 1989; 115():126-31. PubMed ID: 2696025
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant chemotherapy and hormonal therapy for operable breast cancer.
    Minor DR
    Front Radiat Ther Oncol; 1983; 17():115-23. PubMed ID: 6337077
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of breast cancer with hormones and drugs.
    Lippman ME
    Hosp Pract (Off Ed); 1986 May; 21(5):119-27, 131. PubMed ID: 3009506
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant systemic therapy in breast cancer. Part 1: Adjuvant hormone therapy.
    Boyages J; Tiver KW
    Aust N Z J Surg; 1992 May; 62(5):354-63. PubMed ID: 1575655
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized trial of tamoxifen versus aminoglutethimide and versus combined tamoxifen and aminoglutethimide in advanced postmenopausal breast cancer.
    Alonso-Muñoz MC; Ojeda-González MB; Beltran-Fabregat M; Dorca-Ribugent J; López-López L; Borrás-Balada J; Cardenal-Alemany F; Gómez-Batiste X; Fabregat-Mayol J; Viladiu-Quemada P
    Oncology; 1988; 45(5):350-3. PubMed ID: 3045726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of tamoxifen in stage I breast cancer.
    Munar MY; Scholtz JM
    Clin Pharm; 1988 Sep; 7(9):640, 643. PubMed ID: 3240659
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status.
    Rose C; Mouridsen HT; Thorpe SM; Andersen J; Blichert-Toft M; Andersen KW
    World J Surg; 1985 Oct; 9(5):765-74. PubMed ID: 4060747
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant systemic therapy for resectable breast cancer.
    Bonadonna G; Valagussa P
    J Clin Oncol; 1985 Feb; 3(2):259-75. PubMed ID: 3881562
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C.
    Mouridsen HT; Rose C; Overgaard M; Dombernowsky P; Panduro J; Thorpe S; Rasmussen BB; Blichert-Toft M; Andersen KW
    Acta Oncol; 1988; 27(6A):699-705. PubMed ID: 3064775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.